Propafenone Hydrochloride Capsule, Extended Release shortage
To Be DiscontinuedPropafenone Hydrochloride Capsule, Extended Release is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Capsule, Extended Release
Routes
ORAL
Last updated
05/14/2025
Strength variants
- Not specified
Need sourcing help for Propafenone Hydrochloride Capsule, Extended Release?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
- Upsher-Smith Laboratories, LLC800-654-2299To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Cardiovascular
Lidocaine Hydrochloride Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 04/07/2026
Lidocaine Hydrochloride Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 04/07/2026
Lidocaine Hydrochloride Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 04/07/2026
Furosemide Injection
- Category
- Cardiovascular
- Reason
- Not specified
- Updated
- 04/06/2026
Bumetanide Injection
- Category
- Cardiovascular
- Reason
- Demand increase for the drug
- Updated
- 04/06/2026
Bumetanide Injection
- Category
- Cardiovascular
- Reason
- Demand increase for the drug
- Updated
- 04/06/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.